1: GO: Molecular Function [Display Chart]
6 input genes in category / 35 annotations before applied cutoff / 18661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0003887
|
DNA-directed DNA polymerase activity
|
|
3.245E-5
|
1.136E-3
|
4.709E-3
|
1.136E-3
|
2
|
28
|
2
|
GO:0034061
|
DNA polymerase activity
|
|
9.253E-5
|
1.619E-3
|
6.715E-3
|
3.239E-3
|
2
|
47
|
3
|
GO:0051082
|
unfolded protein binding
|
|
4.461E-4
|
5.118E-3
|
2.122E-2
|
1.561E-2
|
2
|
103
|
4
|
GO:0030337
|
DNA polymerase processivity factor activity
|
|
6.430E-4
|
5.118E-3
|
2.122E-2
|
2.250E-2
|
1
|
2
|
5
|
GO:0016779
|
nucleotidyltransferase activity
|
|
7.312E-4
|
5.118E-3
|
2.122E-2
|
2.559E-2
|
2
|
132
|
6
|
GO:0032139
|
dinucleotide insertion or deletion binding
|
|
9.643E-4
|
5.625E-3
|
2.333E-2
|
3.375E-2
|
1
|
3
|
7
|
GO:0032135
|
DNA insertion or deletion binding
|
|
1.928E-3
|
7.497E-3
|
3.109E-2
|
6.748E-2
|
1
|
6
|
8
|
GO:0070087
|
chromo shadow domain binding
|
|
1.928E-3
|
7.497E-3
|
3.109E-2
|
6.748E-2
|
1
|
6
|
9
|
GO:0032405
|
MutLalpha complex binding
|
|
1.928E-3
|
7.497E-3
|
3.109E-2
|
6.748E-2
|
1
|
6
|
10
|
GO:0032404
|
mismatch repair complex binding
|
|
2.570E-3
|
8.994E-3
|
3.730E-2
|
8.994E-2
|
1
|
8
|
11
|
GO:0000701
|
purine-specific mismatch base pair DNA N-glycosylase activity
|
|
3.853E-3
|
1.043E-2
|
4.326E-2
|
1.348E-1
|
1
|
12
|
12
|
GO:0030983
|
mismatched DNA binding
|
|
3.853E-3
|
1.043E-2
|
4.326E-2
|
1.348E-1
|
1
|
12
|
13
|
GO:0070182
|
DNA polymerase binding
|
|
4.173E-3
|
1.043E-2
|
4.326E-2
|
1.461E-1
|
1
|
13
|
14
|
GO:0000700
|
mismatch base pair DNA N-glycosylase activity
|
|
4.173E-3
|
1.043E-2
|
4.326E-2
|
1.461E-1
|
1
|
13
|
15
|
GO:0008574
|
ATP-dependent microtubule motor activity, plus-end-directed
|
|
5.454E-3
|
1.255E-2
|
5.203E-2
|
1.909E-1
|
1
|
17
|
16
|
GO:0019104
|
DNA N-glycosylase activity
|
|
5.774E-3
|
1.255E-2
|
5.203E-2
|
2.021E-1
|
1
|
18
|
17
|
GO:1990939
|
ATP-dependent microtubule motor activity
|
|
6.094E-3
|
1.255E-2
|
5.203E-2
|
2.133E-1
|
1
|
19
|
18
|
GO:0016799
|
hydrolase activity, hydrolyzing N-glycosyl compounds
|
|
8.012E-3
|
1.558E-2
|
6.461E-2
|
2.804E-1
|
1
|
25
|
19
|
GO:0035035
|
histone acetyltransferase binding
|
|
9.608E-3
|
1.770E-2
|
7.340E-2
|
3.363E-1
|
1
|
30
|
20
|
GO:0030507
|
spectrin binding
|
|
1.025E-2
|
1.793E-2
|
7.436E-2
|
3.586E-1
|
1
|
32
|
21
|
GO:0019894
|
kinesin binding
|
|
1.343E-2
|
2.238E-2
|
9.282E-2
|
4.701E-1
|
1
|
42
|
22
|
GO:0030331
|
estrogen receptor binding
|
|
1.502E-2
|
2.389E-2
|
9.908E-2
|
5.257E-1
|
1
|
47
|
23
|
GO:0030971
|
receptor tyrosine kinase binding
|
|
1.914E-2
|
2.913E-2
|
1.208E-1
|
6.699E-1
|
1
|
60
|
24
|
GO:0003684
|
damaged DNA binding
|
|
2.072E-2
|
2.945E-2
|
1.221E-1
|
7.252E-1
|
1
|
65
|
25
|
GO:1990782
|
protein tyrosine kinase binding
|
|
2.104E-2
|
2.945E-2
|
1.221E-1
|
7.363E-1
|
1
|
66
|
26
|
GO:0003777
|
microtubule motor activity
|
|
2.451E-2
|
3.299E-2
|
1.368E-1
|
8.577E-1
|
1
|
77
|
27
|
GO:0035258
|
steroid hormone receptor binding
|
|
2.828E-2
|
3.666E-2
|
1.520E-1
|
9.898E-1
|
1
|
89
|
Show 22 more annotations
|
2: GO: Biological Process [Display Chart]
6 input genes in category / 214 annotations before applied cutoff / 18623 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0006260
|
DNA replication
|
|
1.271E-8
|
2.720E-6
|
1.617E-5
|
2.720E-6
|
5
|
346
|
2
|
GO:0006297
|
nucleotide-excision repair, DNA gap filling
|
|
3.752E-8
|
3.041E-6
|
1.808E-5
|
8.028E-6
|
3
|
24
|
3
|
GO:0006271
|
DNA strand elongation involved in DNA replication
|
|
4.263E-8
|
3.041E-6
|
1.808E-5
|
9.122E-6
|
3
|
25
|
4
|
GO:0022616
|
DNA strand elongation
|
|
8.325E-8
|
3.846E-6
|
2.287E-5
|
1.781E-5
|
3
|
31
|
5
|
GO:0000722
|
telomere maintenance via recombination
|
|
1.108E-7
|
3.846E-6
|
2.287E-5
|
2.371E-5
|
3
|
34
|
6
|
GO:0006298
|
mismatch repair
|
|
1.212E-7
|
3.846E-6
|
2.287E-5
|
2.593E-5
|
3
|
35
|
7
|
GO:0042769
|
DNA damage response, detection of DNA damage
|
|
1.322E-7
|
3.846E-6
|
2.287E-5
|
2.828E-5
|
3
|
36
|
8
|
GO:0006296
|
nucleotide-excision repair, DNA incision, 5'-to lesion
|
|
1.438E-7
|
3.846E-6
|
2.287E-5
|
3.077E-5
|
3
|
37
|
9
|
GO:0033683
|
nucleotide-excision repair, DNA incision
|
|
1.691E-7
|
4.021E-6
|
2.390E-5
|
3.618E-5
|
3
|
39
|
10
|
GO:0019985
|
translesion synthesis
|
|
1.972E-7
|
4.220E-6
|
2.509E-5
|
4.220E-5
|
3
|
41
|
11
|
GO:0006312
|
mitotic recombination
|
|
2.623E-7
|
5.104E-6
|
3.035E-5
|
5.614E-5
|
3
|
45
|
12
|
GO:0006301
|
postreplication repair
|
|
4.581E-7
|
8.169E-6
|
4.857E-5
|
9.803E-5
|
3
|
54
|
13
|
GO:0006283
|
transcription-coupled nucleotide-excision repair
|
|
1.146E-6
|
1.887E-5
|
1.122E-4
|
2.452E-4
|
3
|
73
|
14
|
GO:0000731
|
DNA synthesis involved in DNA repair
|
|
1.244E-6
|
1.901E-5
|
1.130E-4
|
2.662E-4
|
3
|
75
|
15
|
GO:0006289
|
nucleotide-excision repair
|
|
5.017E-6
|
7.158E-5
|
4.256E-4
|
1.074E-3
|
3
|
119
|
16
|
GO:0006261
|
DNA-dependent DNA replication
|
|
7.171E-6
|
9.591E-5
|
5.703E-4
|
1.535E-3
|
3
|
134
|
17
|
GO:0000723
|
telomere maintenance
|
|
8.180E-6
|
1.030E-4
|
6.122E-4
|
1.751E-3
|
3
|
140
|
18
|
GO:0032200
|
telomere organization
|
|
1.068E-5
|
1.270E-4
|
7.549E-4
|
2.286E-3
|
3
|
153
|
19
|
GO:0071897
|
DNA biosynthetic process
|
|
2.797E-5
|
3.150E-4
|
1.873E-3
|
5.985E-3
|
3
|
211
|
20
|
GO:0006335
|
DNA replication-dependent nucleosome assembly
|
|
4.272E-5
|
4.354E-4
|
2.588E-3
|
9.143E-3
|
2
|
32
|
21
|
GO:0034723
|
DNA replication-dependent nucleosome organization
|
|
4.272E-5
|
4.354E-4
|
2.588E-3
|
9.143E-3
|
2
|
32
|
22
|
GO:0006310
|
DNA recombination
|
|
5.645E-5
|
5.491E-4
|
3.265E-3
|
1.208E-2
|
3
|
267
|
23
|
GO:0090305
|
nucleic acid phosphodiester bond hydrolysis
|
|
5.966E-5
|
5.551E-4
|
3.300E-3
|
1.277E-2
|
3
|
272
|
24
|
GO:0060249
|
anatomical structure homeostasis
|
|
1.902E-4
|
1.696E-3
|
1.009E-2
|
4.071E-2
|
3
|
402
|
25
|
GO:0099640
|
axo-dendritic protein transport
|
|
3.222E-4
|
2.377E-3
|
1.414E-2
|
6.895E-2
|
1
|
1
|
26
|
GO:2000769
|
regulation of establishment or maintenance of cell polarity regulating cell shape
|
|
3.222E-4
|
2.377E-3
|
1.414E-2
|
6.895E-2
|
1
|
1
|
27
|
GO:1905128
|
positive regulation of axo-dendritic protein transport
|
|
3.222E-4
|
2.377E-3
|
1.414E-2
|
6.895E-2
|
1
|
1
|
28
|
GO:1905126
|
regulation of axo-dendritic protein transport
|
|
3.222E-4
|
2.377E-3
|
1.414E-2
|
6.895E-2
|
1
|
1
|
29
|
GO:2000771
|
positive regulation of establishment or maintenance of cell polarity regulating cell shape
|
|
3.222E-4
|
2.377E-3
|
1.414E-2
|
6.895E-2
|
1
|
1
|
30
|
GO:0036334
|
epidermal stem cell homeostasis
|
|
6.443E-4
|
4.309E-3
|
2.562E-2
|
1.379E-1
|
1
|
2
|
31
|
GO:0071963
|
establishment or maintenance of cell polarity regulating cell shape
|
|
6.443E-4
|
4.309E-3
|
2.562E-2
|
1.379E-1
|
1
|
2
|
32
|
GO:0006272
|
leading strand elongation
|
|
6.443E-4
|
4.309E-3
|
2.562E-2
|
1.379E-1
|
1
|
2
|
33
|
GO:0006334
|
nucleosome assembly
|
|
8.727E-4
|
5.659E-3
|
3.365E-2
|
1.868E-1
|
2
|
144
|
34
|
GO:1902990
|
mitotic telomere maintenance via semi-conservative replication
|
|
9.663E-4
|
6.082E-3
|
3.616E-2
|
2.068E-1
|
1
|
3
|
35
|
GO:0031497
|
chromatin assembly
|
|
1.103E-3
|
6.741E-3
|
4.008E-2
|
2.359E-1
|
2
|
162
|
36
|
GO:0034728
|
nucleosome organization
|
|
1.227E-3
|
7.295E-3
|
4.337E-2
|
2.626E-1
|
2
|
171
|
37
|
GO:0032077
|
positive regulation of deoxyribonuclease activity
|
|
1.288E-3
|
7.451E-3
|
4.430E-2
|
2.757E-1
|
1
|
4
|
38
|
GO:0006333
|
chromatin assembly or disassembly
|
|
1.481E-3
|
8.338E-3
|
4.957E-2
|
3.168E-1
|
2
|
188
|
39
|
GO:0006323
|
DNA packaging
|
|
1.774E-3
|
9.733E-3
|
5.787E-2
|
3.796E-1
|
2
|
206
|
40
|
GO:0006287
|
base-excision repair, gap-filling
|
|
1.932E-3
|
1.008E-2
|
5.995E-2
|
4.134E-1
|
1
|
6
|
41
|
GO:0032201
|
telomere maintenance via semi-conservative replication
|
|
1.932E-3
|
1.008E-2
|
5.995E-2
|
4.134E-1
|
1
|
6
|
42
|
GO:0065004
|
protein-DNA complex assembly
|
|
2.111E-3
|
1.076E-2
|
6.396E-2
|
4.518E-1
|
2
|
225
|
43
|
GO:0072383
|
plus-end-directed vesicle transport along microtubule
|
|
2.253E-3
|
1.096E-2
|
6.516E-2
|
4.822E-1
|
1
|
7
|
44
|
GO:0072386
|
plus-end-directed organelle transport along microtubule
|
|
2.253E-3
|
1.096E-2
|
6.516E-2
|
4.822E-1
|
1
|
7
|
45
|
GO:0032070
|
regulation of deoxyribonuclease activity
|
|
2.575E-3
|
1.225E-2
|
7.281E-2
|
5.511E-1
|
1
|
8
|
46
|
GO:0071824
|
protein-DNA complex subunit organization
|
|
2.639E-3
|
1.228E-2
|
7.300E-2
|
5.648E-1
|
2
|
252
|
47
|
GO:0071103
|
DNA conformation change
|
|
3.361E-3
|
1.531E-2
|
9.100E-2
|
7.193E-1
|
2
|
285
|
48
|
GO:0032075
|
positive regulation of nuclease activity
|
|
4.824E-3
|
2.151E-2
|
1.279E-1
|
1.000E0
|
1
|
15
|
49
|
GO:0021542
|
dentate gyrus development
|
|
5.465E-3
|
2.387E-2
|
1.419E-1
|
1.000E0
|
1
|
17
|
50
|
GO:0042276
|
error-prone translesion synthesis
|
|
6.107E-3
|
2.562E-2
|
1.523E-1
|
1.000E0
|
1
|
19
|
Show 45 more annotations
|
3: GO: Cellular Component [Display Chart]
6 input genes in category / 40 annotations before applied cutoff / 19061 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GO:0030894
|
replisome
|
|
7.764E-8
|
3.106E-6
|
1.329E-5
|
3.106E-6
|
3
|
31
|
2
|
GO:0043596
|
nuclear replication fork
|
|
1.839E-7
|
3.303E-6
|
1.413E-5
|
7.357E-6
|
3
|
41
|
3
|
GO:0033186
|
CAF-1 complex
|
|
2.477E-7
|
3.303E-6
|
1.413E-5
|
9.908E-6
|
2
|
3
|
4
|
GO:0043625
|
delta DNA polymerase complex
|
|
4.953E-7
|
4.953E-6
|
2.119E-5
|
1.981E-5
|
2
|
4
|
5
|
GO:0005657
|
replication fork
|
|
8.240E-7
|
6.592E-6
|
2.820E-5
|
3.296E-5
|
3
|
67
|
6
|
GO:0042575
|
DNA polymerase complex
|
|
7.502E-6
|
5.001E-5
|
2.140E-4
|
3.001E-4
|
2
|
14
|
7
|
GO:0032993
|
protein-DNA complex
|
|
1.705E-5
|
9.740E-5
|
4.167E-4
|
6.818E-4
|
3
|
183
|
8
|
GO:0043601
|
nuclear replisome
|
|
3.110E-5
|
1.555E-4
|
6.653E-4
|
1.244E-3
|
2
|
28
|
9
|
GO:0061695
|
transferase complex, transferring phosphorus-containing groups
|
|
4.028E-5
|
1.790E-4
|
7.659E-4
|
1.611E-3
|
3
|
244
|
10
|
GO:0044796
|
DNA polymerase processivity factor complex
|
|
3.148E-4
|
1.145E-3
|
4.897E-3
|
1.259E-2
|
1
|
1
|
11
|
GO:0043626
|
PCNA complex
|
|
3.148E-4
|
1.145E-3
|
4.897E-3
|
1.259E-2
|
1
|
1
|
12
|
GO:0070557
|
PCNA-p21 complex
|
|
6.295E-4
|
2.098E-3
|
8.977E-3
|
2.518E-2
|
1
|
2
|
13
|
GO:0016939
|
kinesin II complex
|
|
9.441E-4
|
2.905E-3
|
1.243E-2
|
3.776E-2
|
1
|
3
|
14
|
GO:0005663
|
DNA replication factor C complex
|
|
1.887E-3
|
5.393E-3
|
2.307E-2
|
7.550E-2
|
1
|
6
|
15
|
GO:0097470
|
ribbon synapse
|
|
2.830E-3
|
7.547E-3
|
3.229E-2
|
1.132E-1
|
1
|
9
|
16
|
GO:0005652
|
nuclear lamina
|
|
4.086E-3
|
9.717E-3
|
4.158E-2
|
1.634E-1
|
1
|
13
|
17
|
GO:0000790
|
nuclear chromatin
|
|
4.130E-3
|
9.717E-3
|
4.158E-2
|
1.652E-1
|
2
|
324
|
18
|
GO:0000785
|
chromatin
|
|
9.128E-3
|
2.006E-2
|
8.585E-2
|
3.651E-1
|
2
|
487
|
19
|
GO:0000307
|
cyclin-dependent protein kinase holoenzyme complex
|
|
1.003E-2
|
2.006E-2
|
8.585E-2
|
4.013E-1
|
1
|
32
|
20
|
GO:0030990
|
intraciliary transport particle
|
|
1.003E-2
|
2.006E-2
|
8.585E-2
|
4.013E-1
|
1
|
32
|
21
|
GO:1904115
|
axon cytoplasm
|
|
1.128E-2
|
2.149E-2
|
9.193E-2
|
4.512E-1
|
1
|
36
|
22
|
GO:0032391
|
photoreceptor connecting cilium
|
|
1.253E-2
|
2.278E-2
|
9.745E-2
|
5.011E-1
|
1
|
40
|
23
|
GO:0097542
|
ciliary tip
|
|
1.408E-2
|
2.449E-2
|
1.048E-1
|
5.633E-1
|
1
|
45
|
24
|
GO:0005871
|
kinesin complex
|
|
1.719E-2
|
2.865E-2
|
1.226E-1
|
6.876E-1
|
1
|
55
|
25
|
GO:0005876
|
spindle microtubule
|
|
1.874E-2
|
2.999E-2
|
1.283E-1
|
7.496E-1
|
1
|
60
|
26
|
GO:0032838
|
plasma membrane bounded cell projection cytoplasm
|
|
1.967E-2
|
3.026E-2
|
1.295E-1
|
7.868E-1
|
1
|
63
|
27
|
GO:1902554
|
serine/threonine protein kinase complex
|
|
2.523E-2
|
3.738E-2
|
1.599E-1
|
1.000E0
|
1
|
81
|
28
|
GO:1902911
|
protein kinase complex
|
|
2.862E-2
|
4.088E-2
|
1.749E-1
|
1.000E0
|
1
|
92
|
29
|
GO:0097014
|
ciliary plasm
|
|
3.077E-2
|
4.102E-2
|
1.755E-1
|
1.000E0
|
1
|
99
|
30
|
GO:0005930
|
axoneme
|
|
3.077E-2
|
4.102E-2
|
1.755E-1
|
1.000E0
|
1
|
99
|
Show 25 more annotations
|
4: Human Phenotype [Display Chart]
1 input genes in category / 16 annotations before applied cutoff / 4707 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
HP:0000524
|
Conjunctival telangiectasia
|
|
4.886E-3
|
4.249E-2
|
1.436E-1
|
7.818E-2
|
1
|
23
|
2
|
HP:0008054
|
Abnormal vasculature of the conjunctiva morphology
|
|
5.311E-3
|
4.249E-2
|
1.436E-1
|
8.498E-2
|
1
|
25
|
3
|
HP:0100579
|
Mucosal telangiectasiae
|
|
8.286E-3
|
4.419E-2
|
1.494E-1
|
1.326E-1
|
1
|
39
|
|
5: Mouse Phenotype [Display Chart]
6 input genes in category / 212 annotations before applied cutoff / 10355 genes in category
|
6: Domain [Display Chart]
6 input genes in category / 40 annotations before applied cutoff / 18735 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
PF09507
|
CDC27
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
2
|
PF15557
|
CAF1-p150 N
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
3
|
IPR029129
|
CAF1 p60 C
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
4
|
PF15512
|
CAF-1 p60 C
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
5
|
IPR029105
|
CAF1-p150 C2
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
6
|
IPR019038
|
DNA polymerase subunit Cdc27
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
7
|
IPR022043
|
CAF1A
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
8
|
IPR029091
|
CAF1-p150 N
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
9
|
PF00705
|
PCNA N
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
10
|
PF02747
|
PCNA C
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
11
|
PS00293
|
PCNA 2
|
PROSITE
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
12
|
IPR000730
|
Pr cel nuc antig
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
13
|
PS01251
|
PCNA 1
|
PROSITE
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
14
|
IPR022649
|
Pr cel nuc antig C
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
15
|
IPR022659
|
Pr cel nuc antig CS
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
16
|
IPR024826
|
DNA pol delta/II ssu
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
17
|
PF15539
|
CAF1-p150 C2
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
18
|
IPR022648
|
Pr cel nuc antig N
|
InterPro
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
19
|
PF12253
|
CAF1A
|
Pfam
|
3.203E-4
|
6.742E-4
|
2.885E-3
|
1.281E-2
|
1
|
1
|
20
|
IPR007185
|
DNA pol alpha/epsilon bsu
|
InterPro
|
9.605E-4
|
1.830E-3
|
7.828E-3
|
3.842E-2
|
1
|
3
|
21
|
PF04042
|
DNA pol E B
|
Pfam
|
9.605E-4
|
1.830E-3
|
7.828E-3
|
3.842E-2
|
1
|
3
|
22
|
IPR001632
|
Gprotein B
|
InterPro
|
3.199E-3
|
5.816E-3
|
2.488E-2
|
1.279E-1
|
1
|
10
|
23
|
IPR019821
|
Kinesin motor CS
|
InterPro
|
1.306E-2
|
1.868E-2
|
7.993E-2
|
5.224E-1
|
1
|
41
|
24
|
IPR027640
|
Kinesin-like fam
|
InterPro
|
1.369E-2
|
1.868E-2
|
7.993E-2
|
5.478E-1
|
1
|
43
|
25
|
PF00225
|
Kinesin
|
Pfam
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
26
|
SM00129
|
KISc
|
SMART
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
27
|
3.40.850.10
|
-
|
Gene3D
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
28
|
PS00411
|
KINESIN MOTOR 1
|
PROSITE
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
29
|
IPR001752
|
Kinesin motor dom
|
InterPro
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
30
|
PS50067
|
KINESIN MOTOR 2
|
PROSITE
|
1.401E-2
|
1.868E-2
|
7.993E-2
|
5.604E-1
|
1
|
44
|
Show 25 more annotations
|
7: Pathway [Display Chart]
4 input genes in category / 88 annotations before applied cutoff / 12450 genes in category
|
8: Pubmed [Display Chart]
6 input genes in category / 1670 annotations before applied cutoff / 38193 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
16000169
|
An in vivo analysis of the localisation and interactions of human p66 DNA polymerase delta subunit.
|
Pubmed
|
2.154E-12
|
3.597E-9
|
2.877E-8
|
3.597E-9
|
3
|
3
|
2
|
11328591
|
The human homologue of fission Yeast cdc27, p66, is a component of active human DNA polymerase delta.
|
Pubmed
|
8.616E-12
|
7.194E-9
|
5.754E-8
|
1.439E-8
|
3
|
4
|
3
|
16510448
|
Functional roles of p12, the fourth subunit of human DNA polymerase delta.
|
Pubmed
|
7.538E-11
|
4.196E-8
|
3.356E-7
|
1.259E-7
|
3
|
7
|
4
|
10559261
|
Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins.
|
Pubmed
|
1.809E-10
|
7.552E-8
|
6.040E-7
|
3.021E-7
|
3
|
9
|
5
|
11473323
|
RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes.
|
Pubmed
|
4.736E-10
|
1.582E-7
|
1.265E-6
|
7.910E-7
|
3
|
12
|
6
|
9111189
|
Which DNA polymerases are used for DNA-repair in eukaryotes?
|
Pubmed
|
1.205E-9
|
3.355E-7
|
2.683E-6
|
2.013E-6
|
3
|
16
|
7
|
12171929
|
A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein.
|
Pubmed
|
9.667E-9
|
1.808E-6
|
1.446E-5
|
1.614E-5
|
3
|
31
|
8
|
22148433
|
Phosphorylation of the p68 subunit of Pol δ acts as a molecular switch to regulate its interaction with PCNA.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
9
|
18818516
|
X-ray structure of the complex of regulatory subunits of human DNA polymerase delta.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
10
|
11986310
|
Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase delta.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
11
|
19822659
|
Two fundamentally distinct PCNA interaction peptides contribute to chromatin assembly factor 1 function.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
12
|
18765914
|
Crystallization and preliminary crystallographic analysis of the complex of the second and third regulatory subunits of human Pol delta.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
13
|
7600578
|
The p150 and p60 subunits of chromatin assembly factor I: a molecular link between newly synthesized histones and DNA replication.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
14
|
29382432
|
[Highly expressed CHAF1A and PCNA are positively associated with malignancy of cervical squamous cell carcinoma].
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
15
|
10648606
|
A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
16
|
10893180
|
CAF-1 and the inheritance of chromatin states: at the crossroads of DNA replication and repair.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
17
|
10219083
|
Isolation and identification of the third subunit of mammalian DNA polymerase delta by PCNA-affinity chromatography of mouse FM3A cell extracts.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
18
|
17932049
|
Dynamics of human replication factors in the elongation phase of DNA replication.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
19
|
11595739
|
Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.
|
Pubmed
|
2.057E-8
|
1.808E-6
|
1.446E-5
|
3.435E-5
|
2
|
2
|
20
|
28934474
|
Human DNA polymerase delta double-mutant D316A;E318A interferes with DNA mismatch repair in vitro.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
21
|
10852724
|
Evidence that DNA polymerase delta isolated by immunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein and RPA.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
22
|
11593007
|
A tumor necrosis factor alpha- and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
23
|
15805117
|
Proliferating cell nuclear antigen (PCNA) may function as a double homotrimer complex in the mammalian cell.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
24
|
9614144
|
Nucleosome assembly activity and intracellular localization of human CAF-1 changes during the cell division cycle.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
25
|
22232658
|
Interplay between mismatch repair and chromatin assembly.
|
Pubmed
|
6.170E-8
|
4.121E-6
|
3.296E-5
|
1.030E-4
|
2
|
3
|
26
|
12403614
|
Reconstitution and characterization of the human DNA polymerase delta four-subunit holoenzyme.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
27
|
11897662
|
Human Asf1 and CAF-1 interact and synergize in a repair-coupled nucleosome assembly pathway.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
28
|
15576034
|
Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
29
|
17081972
|
New histone incorporation marks sites of UV repair in human cells.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
30
|
16934752
|
The p66 and p12 subunits of DNA polymerase delta are modified by ubiquitin and ubiquitin-like proteins.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
31
|
8858152
|
Nucleosome assembly by a complex of CAF-1 and acetylated histones H3/H4.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
32
|
12697822
|
The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1.
|
Pubmed
|
1.234E-7
|
6.439E-6
|
5.150E-5
|
2.060E-4
|
2
|
4
|
33
|
19237606
|
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.
|
Pubmed
|
2.043E-7
|
8.805E-6
|
7.042E-5
|
3.411E-4
|
3
|
84
|
34
|
12771185
|
BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
35
|
24695737
|
The ADP-ribosyltransferase PARP10/ARTD10 interacts with proliferating cell nuclear antigen (PCNA) and is required for DNA damage tolerance.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
36
|
17065558
|
Essential role of chromatin assembly factor-1-mediated rapid nucleosome assembly for DNA replication and cell division in vertebrate cells.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
37
|
24939902
|
CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
38
|
15327775
|
Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
39
|
12522211
|
Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen.
|
Pubmed
|
2.056E-7
|
8.805E-6
|
7.042E-5
|
3.434E-4
|
2
|
5
|
40
|
19845771
|
Dmap1 plays an essential role in the maintenance of genome integrity through the DNA repair process.
|
Pubmed
|
3.084E-7
|
1.256E-5
|
1.005E-4
|
5.151E-4
|
2
|
6
|
41
|
16826239
|
The replication kinase Cdc7-Dbf4 promotes the interaction of the p150 subunit of chromatin assembly factor 1 with proliferating cell nuclear antigen.
|
Pubmed
|
3.084E-7
|
1.256E-5
|
1.005E-4
|
5.151E-4
|
2
|
6
|
42
|
15306854
|
A CAF-1 dependent pool of HP1 during heterochromatin duplication.
|
Pubmed
|
4.318E-7
|
1.717E-5
|
1.373E-4
|
7.210E-4
|
2
|
7
|
43
|
22195966
|
Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity.
|
Pubmed
|
5.756E-7
|
2.236E-5
|
1.788E-4
|
9.613E-4
|
2
|
8
|
44
|
20227374
|
Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells.
|
Pubmed
|
7.400E-7
|
2.746E-5
|
2.197E-4
|
1.236E-3
|
2
|
9
|
45
|
16763556
|
Controlling the subcellular localization of DNA polymerases iota and eta via interactions with ubiquitin.
|
Pubmed
|
7.400E-7
|
2.746E-5
|
2.197E-4
|
1.236E-3
|
2
|
9
|
46
|
21724829
|
Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly.
|
Pubmed
|
1.130E-6
|
4.104E-5
|
3.282E-4
|
1.888E-3
|
2
|
11
|
47
|
26365490
|
Systematic identification of factors for provirus silencing in embryonic stem cells.
|
Pubmed
|
1.201E-6
|
4.268E-5
|
3.413E-4
|
2.006E-3
|
3
|
151
|
48
|
17452450
|
Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth.
|
Pubmed
|
1.356E-6
|
4.719E-5
|
3.775E-4
|
2.265E-3
|
2
|
12
|
49
|
29754823
|
Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis.
|
Pubmed
|
1.603E-6
|
5.354E-5
|
4.282E-4
|
2.677E-3
|
2
|
13
|
50
|
15882967
|
The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain.
|
Pubmed
|
1.603E-6
|
5.354E-5
|
4.282E-4
|
2.677E-3
|
2
|
13
|
Show 45 more annotations
|
9: Interaction [Display Chart]
6 input genes in category / 590 annotations before applied cutoff / 17703 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
int:POLD4
|
POLD4 interactions
|
|
4.754E-9
|
2.805E-6
|
1.952E-5
|
2.805E-6
|
3
|
12
|
2
|
int:PCNA
|
PCNA interactions
|
|
1.106E-8
|
3.263E-6
|
2.270E-5
|
6.526E-6
|
5
|
320
|
3
|
int:POLD3
|
POLD3 interactions
|
|
1.289E-7
|
2.536E-5
|
1.764E-4
|
7.608E-5
|
3
|
34
|
4
|
int:POLD2
|
POLD2 interactions
|
|
1.817E-7
|
2.680E-5
|
1.865E-4
|
1.072E-4
|
3
|
38
|
5
|
int:CHAF1B
|
CHAF1B interactions
|
|
3.053E-7
|
3.603E-5
|
2.507E-4
|
1.801E-4
|
3
|
45
|
6
|
int:WRN
|
WRN interactions
|
|
5.638E-7
|
5.544E-5
|
3.858E-4
|
3.326E-4
|
3
|
55
|
7
|
int:TIMELESS
|
TIMELESS interactions
|
|
1.390E-6
|
1.171E-4
|
8.150E-4
|
8.199E-4
|
3
|
74
|
8
|
int:SPRTN
|
SPRTN interactions
|
|
3.352E-6
|
2.334E-4
|
1.624E-3
|
1.978E-3
|
3
|
99
|
9
|
int:HIST2H3C
|
HIST2H3C interactions
|
|
3.560E-6
|
2.334E-4
|
1.624E-3
|
2.101E-3
|
3
|
101
|
10
|
int:POLD1
|
POLD1 interactions
|
|
5.546E-6
|
3.131E-4
|
2.178E-3
|
3.272E-3
|
3
|
117
|
11
|
int:CBX1
|
CBX1 interactions
|
|
5.837E-6
|
3.131E-4
|
2.178E-3
|
3.444E-3
|
3
|
119
|
12
|
int:SETDB1
|
SETDB1 interactions
|
|
1.194E-5
|
5.871E-4
|
4.085E-3
|
7.045E-3
|
3
|
151
|
13
|
int:HIST1H3E
|
HIST1H3E interactions
|
|
2.897E-5
|
1.181E-3
|
8.221E-3
|
1.709E-2
|
3
|
203
|
14
|
int:LIG1
|
LIG1 interactions
|
|
3.348E-5
|
1.181E-3
|
8.221E-3
|
1.975E-2
|
2
|
27
|
15
|
int:REV1
|
REV1 interactions
|
|
3.348E-5
|
1.181E-3
|
8.221E-3
|
1.975E-2
|
2
|
27
|
16
|
int:HIST1H3B
|
HIST1H3B interactions
|
|
3.348E-5
|
1.181E-3
|
8.221E-3
|
1.975E-2
|
2
|
27
|
17
|
int:CHAF1A
|
CHAF1A interactions
|
|
3.487E-5
|
1.181E-3
|
8.221E-3
|
2.057E-2
|
3
|
216
|
18
|
int:KCTD13
|
KCTD13 interactions
|
|
3.604E-5
|
1.181E-3
|
8.221E-3
|
2.127E-2
|
2
|
28
|
19
|
int:RBBP4
|
RBBP4 interactions
|
|
4.428E-5
|
1.375E-3
|
9.568E-3
|
2.613E-2
|
3
|
234
|
20
|
int:CNOT6L
|
CNOT6L interactions
|
|
5.031E-5
|
1.484E-3
|
1.033E-2
|
2.968E-2
|
2
|
33
|
21
|
int:HIST1H4F
|
HIST1H4F interactions
|
|
7.054E-5
|
1.982E-3
|
1.379E-2
|
4.162E-2
|
2
|
39
|
22
|
int:MBD1
|
MBD1 interactions
|
|
7.804E-5
|
2.093E-3
|
1.456E-2
|
4.604E-2
|
2
|
41
|
23
|
int:POLH
|
POLH interactions
|
|
8.591E-5
|
2.204E-3
|
1.533E-2
|
5.069E-2
|
2
|
43
|
24
|
int:WRNIP1
|
WRNIP1 interactions
|
|
1.028E-4
|
2.527E-3
|
1.758E-2
|
6.064E-2
|
2
|
47
|
25
|
int:DNAJC9
|
DNAJC9 interactions
|
|
1.072E-4
|
2.531E-3
|
1.761E-2
|
6.327E-2
|
2
|
48
|
26
|
int:ASF1B
|
ASF1B interactions
|
|
1.569E-4
|
3.561E-3
|
2.478E-2
|
9.258E-2
|
2
|
58
|
27
|
int:POLA1
|
POLA1 interactions
|
|
1.853E-4
|
4.048E-3
|
2.817E-2
|
1.093E-1
|
2
|
63
|
28
|
int:DMAP1
|
DMAP1 interactions
|
|
2.421E-4
|
4.926E-3
|
3.428E-2
|
1.429E-1
|
2
|
72
|
29
|
int:RFC2
|
RFC2 interactions
|
|
2.421E-4
|
4.926E-3
|
3.428E-2
|
1.429E-1
|
2
|
72
|
30
|
int:POLDIP2
|
POLDIP2 interactions
|
|
2.558E-4
|
5.030E-3
|
3.500E-2
|
1.509E-1
|
2
|
74
|
31
|
int:RFC5
|
RFC5 interactions
|
|
2.990E-4
|
5.690E-3
|
3.959E-2
|
1.764E-1
|
2
|
80
|
32
|
int:RFC1
|
RFC1 interactions
|
|
3.296E-4
|
5.824E-3
|
4.052E-2
|
1.945E-1
|
2
|
84
|
33
|
int:HUS1
|
HUS1 interactions
|
|
3.296E-4
|
5.824E-3
|
4.052E-2
|
1.945E-1
|
2
|
84
|
34
|
int:ASF1A
|
ASF1A interactions
|
|
3.455E-4
|
5.824E-3
|
4.052E-2
|
2.038E-1
|
2
|
86
|
35
|
int:H3F3B
|
H3F3B interactions
|
|
3.455E-4
|
5.824E-3
|
4.052E-2
|
2.038E-1
|
2
|
86
|
36
|
int:RPA1
|
RPA1 interactions
|
|
4.129E-4
|
6.768E-3
|
4.709E-2
|
2.436E-1
|
3
|
497
|
37
|
int:MSH6
|
MSH6 interactions
|
|
5.146E-4
|
7.990E-3
|
5.560E-2
|
3.036E-1
|
2
|
105
|
38
|
int:UHRF2
|
UHRF2 interactions
|
|
5.146E-4
|
7.990E-3
|
5.560E-2
|
3.036E-1
|
2
|
105
|
39
|
int:DNMT1
|
DNMT1 interactions
|
|
5.957E-4
|
9.012E-3
|
6.271E-2
|
3.515E-1
|
2
|
113
|
40
|
int:TEAD2
|
TEAD2 interactions
|
|
6.276E-4
|
9.258E-3
|
6.442E-2
|
3.703E-1
|
2
|
116
|
41
|
int:MTA1
|
MTA1 interactions
|
|
7.283E-4
|
1.048E-2
|
7.292E-2
|
4.297E-1
|
2
|
125
|
42
|
int:MCM4
|
MCM4 interactions
|
|
8.738E-4
|
1.228E-2
|
8.541E-2
|
5.156E-1
|
2
|
137
|
43
|
int:SMARCAD1
|
SMARCAD1 interactions
|
|
9.647E-4
|
1.324E-2
|
9.211E-2
|
5.692E-1
|
2
|
144
|
44
|
int:MSH2
|
MSH2 interactions
|
|
1.060E-3
|
1.421E-2
|
9.891E-2
|
6.254E-1
|
2
|
151
|
45
|
int:SOX12
|
SOX12 interactions
|
|
1.355E-3
|
1.638E-2
|
1.140E-1
|
7.995E-1
|
1
|
4
|
46
|
int:SBNO2
|
SBNO2 interactions
|
|
1.355E-3
|
1.638E-2
|
1.140E-1
|
7.995E-1
|
1
|
4
|
47
|
int:PARPBP
|
PARPBP interactions
|
|
1.355E-3
|
1.638E-2
|
1.140E-1
|
7.995E-1
|
1
|
4
|
48
|
int:ATG9B
|
ATG9B interactions
|
|
1.355E-3
|
1.638E-2
|
1.140E-1
|
7.995E-1
|
1
|
4
|
49
|
int:SET
|
SET interactions
|
|
1.372E-3
|
1.638E-2
|
1.140E-1
|
8.096E-1
|
2
|
172
|
50
|
int:H3F3A
|
H3F3A interactions
|
|
1.388E-3
|
1.638E-2
|
1.140E-1
|
8.189E-1
|
2
|
173
|
Show 45 more annotations
|
10: Cytoband [Display Chart]
5 input genes in category / 5 annotations before applied cutoff / 34661 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
11q14
|
11q14
|
|
1.730E-3
|
6.125E-3
|
1.399E-2
|
8.650E-3
|
1
|
12
|
2
|
21q22.13
|
21q22.13
|
|
2.450E-3
|
6.125E-3
|
1.399E-2
|
1.225E-2
|
1
|
17
|
3
|
7p13
|
7p13
|
|
5.901E-3
|
9.835E-3
|
2.246E-2
|
2.950E-2
|
1
|
41
|
4
|
5q31
|
5q31
|
|
1.648E-2
|
2.060E-2
|
4.704E-2
|
8.240E-2
|
1
|
115
|
5
|
19p13.3
|
19p13.3
|
|
3.513E-2
|
3.513E-2
|
8.021E-2
|
1.756E-1
|
1
|
247
|
|
11: Transcription Factor Binding Site [Display Chart]
2 input genes in category / 19 annotations before applied cutoff / 9770 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
GTTRYCATRR UNKNOWN
|
GTTRYCATRR UNKNOWN
|
|
2.603E-2
|
4.932E-2
|
1.750E-1
|
4.946E-1
|
1
|
128
|
2
|
SGCGSSAAA V$E2F1DP2 01
|
SGCGSSAAA V$E2F1DP2 01
|
|
2.664E-2
|
4.932E-2
|
1.750E-1
|
5.061E-1
|
1
|
131
|
3
|
V$E2F1 Q6
|
V$E2F1 Q6
|
|
3.671E-2
|
4.932E-2
|
1.750E-1
|
6.975E-1
|
1
|
181
|
4
|
V$E2F Q6
|
V$E2F Q6
|
|
3.691E-2
|
4.932E-2
|
1.750E-1
|
7.013E-1
|
1
|
182
|
5
|
V$E2F1DP2 01
|
V$E2F1DP2 01
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
6
|
V$E2F 02
|
V$E2F 02
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
7
|
V$E2F Q4
|
V$E2F Q4
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
8
|
V$E2F1DP1 01
|
V$E2F1DP1 01
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
9
|
V$E2F4DP2 01
|
V$E2F4DP2 01
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
10
|
V$E2F1DP1RB 01
|
V$E2F1DP1RB 01
|
|
3.731E-2
|
4.932E-2
|
1.750E-1
|
7.090E-1
|
1
|
184
|
11
|
V$E2F1 Q6 01
|
V$E2F1 Q6 01
|
|
3.832E-2
|
4.932E-2
|
1.750E-1
|
7.280E-1
|
1
|
189
|
12
|
V$E2F4DP1 01
|
V$E2F4DP1 01
|
|
3.832E-2
|
4.932E-2
|
1.750E-1
|
7.280E-1
|
1
|
189
|
13
|
V$E2F1 Q3
|
V$E2F1 Q3
|
|
3.852E-2
|
4.932E-2
|
1.750E-1
|
7.318E-1
|
1
|
190
|
14
|
V$HMGIY Q6
|
V$HMGIY Q6
|
|
3.932E-2
|
4.932E-2
|
1.750E-1
|
7.471E-1
|
1
|
194
|
15
|
V$AP2 Q6
|
V$AP2 Q6
|
|
4.073E-2
|
4.932E-2
|
1.750E-1
|
7.738E-1
|
1
|
201
|
16
|
V$MTF1 Q4
|
V$MTF1 Q4
|
|
4.273E-2
|
4.932E-2
|
1.750E-1
|
8.119E-1
|
1
|
211
|
17
|
V$IRF1 Q6
|
V$IRF1 Q6
|
|
4.413E-2
|
4.932E-2
|
1.750E-1
|
8.385E-1
|
1
|
218
|
Show 12 more annotations
|
12: Gene Family [Display Chart]
4 input genes in category / 4 annotations before applied cutoff / 18194 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
535
|
DNA polymerases
|
genenames.org
|
9.158E-6
|
3.663E-5
|
7.632E-5
|
3.663E-5
|
2
|
23
|
2
|
622
|
Kinesins|Protein phosphatase 1 regulatory subunits
|
genenames.org
|
1.008E-2
|
2.015E-2
|
4.198E-2
|
4.030E-2
|
1
|
46
|
|
13: Coexpression [Display Chart]
6 input genes in category / 836 annotations before applied cutoff / 23137 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
M9372
|
Genes involved in DNA replication, compiled manually by the authors.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.576E-11
|
4.661E-8
|
3.406E-7
|
4.661E-8
|
5
|
146
|
2
|
M11563
|
Genes involved in DNA repair, compiled manually by the authors.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.532E-10
|
2.312E-7
|
1.690E-6
|
4.625E-7
|
5
|
230
|
3
|
M2156
|
Genes up-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChem=5757] treatment.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.098E-9
|
8.632E-7
|
6.307E-6
|
2.590E-6
|
5
|
324
|
4
|
M2074
|
Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G1/S phase of cell cycle.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.323E-8
|
4.855E-6
|
3.548E-5
|
1.942E-5
|
4
|
147
|
5
|
M4523
|
Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus stimulated CD4 [GeneID=920] Th1 cells at 12 h.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
8.018E-8
|
1.341E-5
|
9.795E-5
|
6.703E-5
|
4
|
200
|
6
|
20548326-Table4
|
Human Stomach Bonelli10 61genes
|
GeneSigDB
|
3.298E-7
|
4.595E-5
|
3.357E-4
|
2.757E-4
|
3
|
60
|
7
|
M15969
|
Cluster 1: genes up-regulated by RB1, CDNK2A [GeneID=1029;5925], and one of the E2Fs (E2F1, E2F2, or E2F3 [GeneID=1869;1870;1871]).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.270E-7
|
5.999E-5
|
4.383E-4
|
4.405E-4
|
3
|
70
|
8
|
M10739
|
Genes down-regulated in ANBL-6 cell line (multiple myeloma, MM) expressing a constantly active form of NRAS [GeneID=4893] off a plasmid vector compared to those grown in the presence of IL6 [GeneID=3569].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.740E-7
|
5.999E-5
|
4.383E-4
|
4.799E-4
|
3
|
72
|
9
|
15260889-TableS2a
|
Human Breast Dairkee04 479genes
|
GeneSigDB
|
9.012E-7
|
8.371E-5
|
6.116E-4
|
7.534E-4
|
4
|
366
|
10
|
M7715
|
Top 100 genes negatively associated with T-cell acute lymphoblastic leukemia MLL T-ALL) expressing MLL-ENL fusion [GeneID=4297;4298].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.019E-6
|
8.516E-5
|
6.222E-4
|
8.516E-4
|
3
|
87
|
11
|
M9516
|
Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.605E-6
|
1.220E-4
|
8.913E-4
|
1.342E-3
|
4
|
423
|
12
|
15896717-Table6
|
Human Leukemia Bal05 15genes
|
GeneSigDB
|
5.876E-6
|
4.093E-4
|
2.991E-3
|
4.912E-3
|
2
|
15
|
13
|
M7551
|
Genes down-regulated in double positive thymocytes stimulated by anti-CD3: wildtype versus ELK1 [GeneID=2002] knockout.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
1.230E-5
|
6.139E-4
|
4.486E-3
|
1.028E-2
|
3
|
199
|
14
|
M4587
|
Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 3.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
1.248E-5
|
6.139E-4
|
4.486E-3
|
1.044E-2
|
3
|
200
|
15
|
M5925
|
Genes encoding cell cycle related targets of E2F transcription factors.
|
MSigDB H: Hallmark Gene Sets (v6.0)
|
1.248E-5
|
6.139E-4
|
4.486E-3
|
1.044E-2
|
3
|
200
|
16
|
M9767
|
Genes up-regulated in CD4 [GeneID=920] SMARTA effector T cells during acute infection of LCMV: Th1 versus Ly6c low CXCR5- [GeneID=643].
|
MSigDB C7: Immunologic Signatures (v6.0)
|
1.248E-5
|
6.139E-4
|
4.486E-3
|
1.044E-2
|
3
|
200
|
17
|
M8325
|
Genes down-regulated in follicular helper T cells: BCL6 [GeneID=604] high versus BCL6 [GeneID=604] low.
|
MSigDB C7: Immunologic Signatures (v6.0)
|
1.248E-5
|
6.139E-4
|
4.486E-3
|
1.044E-2
|
3
|
200
|
18
|
11861292-Table2
|
Human BoneMarrow Zhan02 30genes
|
GeneSigDB
|
2.268E-5
|
1.053E-3
|
7.697E-3
|
1.896E-2
|
2
|
29
|
19
|
M17405
|
Top genes up-regulated in MM4 vs MM1 subgroup of multiple myeloma samples.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.430E-5
|
1.069E-3
|
7.812E-3
|
2.032E-2
|
2
|
30
|
20
|
M123
|
Genes constituting the PluriNet protein-protein network shared by the pluripotent cells (embryonic stem cells, embryonical carcinomas and induced pluripotent cells).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
4.152E-5
|
1.736E-3
|
1.268E-2
|
3.471E-2
|
3
|
299
|
21
|
M19745
|
Genes down-regulated in mature plasma cells compared with plasmablastic B lymphocytes.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
4.536E-5
|
1.806E-3
|
1.319E-2
|
3.792E-2
|
3
|
308
|
22
|
M854
|
Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.470E-5
|
2.079E-3
|
1.519E-2
|
4.573E-2
|
3
|
328
|
23
|
11559565-Table2
|
Human Brain Rickman01 50genes
|
GeneSigDB
|
6.027E-5
|
2.158E-3
|
1.577E-2
|
5.039E-2
|
2
|
47
|
24
|
M2879
|
Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
6.195E-5
|
2.158E-3
|
1.577E-2
|
5.179E-2
|
3
|
342
|
25
|
M2257
|
Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
9.854E-5
|
3.154E-3
|
2.304E-2
|
8.238E-2
|
2
|
60
|
26
|
M2431
|
DNA repair and replication genes up-regulated in melanoma patients who will relapse vs patients who will not.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
1.019E-4
|
3.154E-3
|
2.304E-2
|
8.516E-2
|
2
|
61
|
27
|
12941627-table1a
|
Mouse StemCell Karsten03 71genes
|
GeneSigDB
|
1.019E-4
|
3.154E-3
|
2.304E-2
|
8.516E-2
|
2
|
61
|
28
|
14750170-Table2
|
Mouse Intestine DeGiovanni04 68genes
|
GeneSigDB
|
1.157E-4
|
3.455E-3
|
2.525E-2
|
9.675E-2
|
2
|
65
|
29
|
15958547-SuppTable3
|
Human Pancreas Qian05 94genes
|
GeneSigDB
|
1.343E-4
|
3.871E-3
|
2.828E-2
|
1.123E-1
|
2
|
70
|
30
|
15489886-TableS1b
|
Human Sarcoma Mason04 549genes
|
GeneSigDB
|
1.532E-4
|
4.270E-3
|
3.120E-2
|
1.281E-1
|
3
|
464
|
31
|
15374877-Table2
|
Human StemCell Manalo05 108genes
|
GeneSigDB
|
1.799E-4
|
4.818E-3
|
3.520E-2
|
1.504E-1
|
2
|
81
|
32
|
19061838-TableS16
|
Human Viral Cairo08 88genes
|
GeneSigDB
|
1.844E-4
|
4.818E-3
|
3.520E-2
|
1.542E-1
|
2
|
82
|
33
|
12874028-Table1
|
Human Esophagus Barrett03 104genes
|
GeneSigDB
|
2.476E-4
|
6.272E-3
|
4.582E-2
|
2.070E-1
|
2
|
95
|
34
|
M18506
|
Genes down-regulated in the ANBL-6 cell line (multiple myeloma, MM) after withdrawal of IL6 [GeneID=3569].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
2.634E-4
|
6.478E-3
|
4.733E-2
|
2.202E-1
|
2
|
98
|
35
|
M1836
|
Up-regulated genes in NMuMG cells (mammary epithelium) after stimulation with WNT3A [GeneID=89780].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.440E-4
|
8.216E-3
|
6.003E-2
|
2.876E-1
|
2
|
112
|
36
|
M2895
|
Genes up-regulated in MEF cells (embryonic fibroblasts) isolated from RB1 [GeneID=5925] knockout mice: chronic loss of function (LOF) of RB1.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.626E-4
|
8.398E-3
|
6.136E-2
|
3.031E-1
|
2
|
115
|
37
|
M15305
|
Genes constituting the BRCA-centered network (BCN).
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.753E-4
|
8.398E-3
|
6.136E-2
|
3.137E-1
|
2
|
117
|
38
|
M18086
|
'Cancer prone response profile' (CPRP): genes common to estradiol and bisphenol A [PubChem=5757;6623] response of epithelial cell cultures from patients at high risk of breast cancer.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
3.817E-4
|
8.398E-3
|
6.136E-2
|
3.191E-1
|
2
|
118
|
39
|
M6866
|
Genes down-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
4.080E-4
|
8.745E-3
|
6.390E-2
|
3.411E-1
|
2
|
122
|
40
|
M2802
|
Genes up-regulated in primary keratinocytes from RB1 and RBL1 [Gene ID=5925, 5933] skin specific knockout mice.
|
MSigDB C6: Oncogenic Signatures (v6.0)
|
5.291E-4
|
9.593E-3
|
7.009E-2
|
4.423E-1
|
2
|
139
|
41
|
M15664
|
The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.367E-4
|
9.593E-3
|
7.009E-2
|
4.487E-1
|
2
|
140
|
42
|
M6506
|
Genes up-regulated by MYC [GeneID=4609] and whose promoters are bound by MYC, according to MYC Target Gene Database.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.598E-4
|
9.593E-3
|
7.009E-2
|
4.680E-1
|
2
|
143
|
43
|
M10633
|
Genes which comprise the top 1% of highly interconnected genes (major hubs) that account for most of gene interactions in the reconstructed regulatory networks from expression profiles in B lymphocytes.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.598E-4
|
9.593E-3
|
7.009E-2
|
4.680E-1
|
2
|
143
|
44
|
M2114
|
Set 'Proliferation Cluster': genes defined in human breast tumor expression data.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
5.914E-4
|
9.593E-3
|
7.009E-2
|
4.944E-1
|
2
|
147
|
45
|
M5898
|
Genes involved in DNA repair.
|
MSigDB H: Hallmark Gene Sets (v6.0)
|
6.157E-4
|
9.593E-3
|
7.009E-2
|
5.147E-1
|
2
|
150
|
46
|
12925741-Figure8
|
Human Lymphoma Jenner03 279genes
|
GeneSigDB
|
6.404E-4
|
9.593E-3
|
7.009E-2
|
5.354E-1
|
2
|
153
|
47
|
M13108
|
Genes down-regulated in Wilm's tumor samples compared to fetal kidney.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
7.263E-4
|
9.593E-3
|
7.009E-2
|
6.072E-1
|
2
|
163
|
48
|
19043454-TableS2
|
Human Breast Thorner09 217genes
|
GeneSigDB
|
7.622E-4
|
9.593E-3
|
7.009E-2
|
6.372E-1
|
2
|
167
|
49
|
M18811
|
Genes constituting the XPRSS-Int network: intersection of genes whose expression correlates with BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200] in a compendium of normal tissues.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
7.713E-4
|
9.593E-3
|
7.009E-2
|
6.448E-1
|
2
|
168
|
50
|
M4288
|
Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.
|
MSigDB C2: CGP Curated Gene Sets (v6.0)
|
8.845E-4
|
9.593E-3
|
7.009E-2
|
7.394E-1
|
2
|
180
|
Show 45 more annotations
|
14: Coexpression Atlas [Display Chart]
6 input genes in category / 333 annotations before applied cutoff / 21829 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Marrow/Slamf1-positive multipotent progenitor cell
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Marrow/Slamf1-positive multipotent progenitor cell
|
Tabula Muris Consortium
|
8.404E-8
|
2.799E-5
|
1.787E-4
|
2.799E-5
|
4
|
191
|
2
|
Adult Brain Overview (690k cells, 9 regions, 565 cell clusters) BrainAtlas - Mouse McCarroll Neurogenesis Top 200
|
Adult Brain Overview (690k cells, 9 regions, 565 cell clusters) BrainAtlas - Mouse McCarroll Neurogenesis Top 200
|
|
6.643E-7
|
5.531E-5
|
3.532E-4
|
2.212E-4
|
4
|
320
|
3
|
Adult Brain Overview (690k cells, 9 regions, 565 cell clusters) BrainAtlas - Mouse McCarroll Neurogenesis Subtype Sox4.Hist1h2al Top 200 Genes
|
Adult Brain Overview (690k cells, 9 regions, 565 cell clusters) BrainAtlas - Mouse McCarroll Neurogenesis Subtype Sox4.Hist1h2al Top 200 Genes
|
|
6.643E-7
|
5.531E-5
|
3.532E-4
|
2.212E-4
|
4
|
320
|
4
|
BrainMap BrainAtlas - Mouse McCarroll Neurogenesis.neurons.immature.Sox4 Neurogenesis.neurons.immature.Sox4 Subtype Neurogenesis.neurons.immature.Sox4.Hist1h2al Top 200 Genes
|
BrainMap BrainAtlas - Mouse McCarroll Neurogenesis.neurons.immature.Sox4 Neurogenesis.neurons.immature.Sox4 Subtype Neurogenesis.neurons.immature.Sox4.Hist1h2al Top 200 Genes
|
BrainMap
|
6.643E-7
|
5.531E-5
|
3.532E-4
|
2.212E-4
|
4
|
320
|
5
|
Mouse Cell Atlas Mouse Regional GI Enterocytes Transit amplifying Enterocyte progenitor Transit amplifying Enterocyte progenitor Subtype transit amplifying progenitor Ileum Top 200 Genes
|
Mouse Cell Atlas Mouse Regional GI Enterocytes Transit amplifying Enterocyte progenitor Transit amplifying Enterocyte progenitor Subtype transit amplifying progenitor Ileum Top 200 Genes
|
Mouse Cell Atlas
|
7.047E-5
|
3.470E-3
|
2.216E-2
|
2.346E-2
|
3
|
337
|
6
|
GSM791154 500
|
alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
9.756E-5
|
3.470E-3
|
2.216E-2
|
3.249E-2
|
3
|
376
|
7
|
10X Human 8K PBMC unknown Subtype unknown-T cell CD4 - B Top 200 Genes
|
10X Human 8K PBMC unknown Subtype unknown-T cell CD4 - B Top 200 Genes
|
|
1.104E-4
|
3.470E-3
|
2.216E-2
|
3.677E-2
|
3
|
392
|
8
|
GSM791143 500
|
alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
1.146E-4
|
3.470E-3
|
2.216E-2
|
3.817E-2
|
3
|
397
|
9
|
GSM791119 500
|
Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
1.225E-4
|
3.470E-3
|
2.216E-2
|
4.080E-2
|
3
|
406
|
10
|
GSM791149 500
|
alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3
|
Immgen.org, GSE15907
|
1.289E-4
|
3.470E-3
|
2.216E-2
|
4.292E-2
|
3
|
413
|
11
|
GSM791134 500
|
alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2
|
Immgen.org, GSE15907
|
1.307E-4
|
3.470E-3
|
2.216E-2
|
4.354E-2
|
3
|
415
|
12
|
GSM476664 500
|
gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3
|
Immgen.org, GSE15907
|
1.345E-4
|
3.470E-3
|
2.216E-2
|
4.479E-2
|
3
|
419
|
13
|
GSM791136 500
|
alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3
|
Immgen.org, GSE15907
|
1.355E-4
|
3.470E-3
|
2.216E-2
|
4.511E-2
|
3
|
420
|
14
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Overall Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Overall Top 100 Genes
|
|
3.018E-4
|
7.179E-3
|
4.585E-2
|
1.005E-1
|
2
|
99
|
15
|
gudmap dev gonad e11.5 M GonadVasMes Flk k3 1000
|
dev gonad e11.5 M GonadVasMes Flk k-means-cluster#3 top-relative-expression-ranked 1000
|
Gudmap Mouse ST 1.0
|
4.655E-4
|
1.033E-2
|
6.600E-2
|
1.550E-1
|
2
|
123
|
16
|
Sample Type by Project: Shred 1/TCGA-Bone and Soft Tissue/Sarcoma/Malignant Peripheral Nerve Sheath Tumors /1
|
Sample Type by Project: Shred 1/TCGA-Bone and Soft Tissue/Sarcoma/Malignant Peripheral Nerve Sheath Tumors /1
|
TCGA-Bone and Soft Tissue
|
6.283E-4
|
1.227E-2
|
7.837E-2
|
2.092E-1
|
2
|
143
|
17
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.3 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.3 Top 100 Genes
|
|
6.548E-4
|
1.227E-2
|
7.837E-2
|
2.181E-1
|
2
|
146
|
18
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.2 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.2 Top 100 Genes
|
|
6.910E-4
|
1.227E-2
|
7.837E-2
|
2.301E-1
|
2
|
150
|
19
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.1 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.1 Top 100 Genes
|
|
7.002E-4
|
1.227E-2
|
7.837E-2
|
2.332E-1
|
2
|
151
|
20
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.0.2 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.0.2 Top 100 Genes
|
|
7.855E-4
|
1.268E-2
|
8.098E-2
|
2.616E-1
|
2
|
160
|
21
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.0.4 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.0.4 Top 100 Genes
|
|
8.451E-4
|
1.268E-2
|
8.098E-2
|
2.814E-1
|
2
|
166
|
22
|
6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s2 intermediate neurons Subtype intermediate neurons s2 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s2 intermediate neurons Subtype intermediate neurons s2 Top 100 Genes
|
|
8.655E-4
|
1.268E-2
|
8.098E-2
|
2.882E-1
|
2
|
168
|
23
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.5 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.5 Top 100 Genes
|
|
8.757E-4
|
1.268E-2
|
8.098E-2
|
2.916E-1
|
2
|
169
|
24
|
6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s3 intermediate neurons Subtype intermediate neurons s3 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Subtype intermediate neurons s3 intermediate neurons Subtype intermediate neurons s3 Top 100 Genes
|
|
9.385E-4
|
1.293E-2
|
8.258E-2
|
3.125E-1
|
2
|
175
|
25
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.4 Top 100 Genes
|
6mo cortical organoids wt 6mo cortical organoids wt Intermediate.0 Intermediate.0 Subtype int.01.4 Top 100 Genes
|
|
9.707E-4
|
1.293E-2
|
8.258E-2
|
3.232E-1
|
2
|
178
|
26
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Erythroblast/Kidney Normal-Cortex Wilms Erythroblast
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Erythroblast/Kidney Normal-Cortex Wilms Erythroblast
|
Adult, Development, and Cancer types
|
1.116E-3
|
1.391E-2
|
8.885E-2
|
3.717E-1
|
2
|
191
|
27
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Marrow/megakaryocyte-erythroid progenitor cell
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Marrow/megakaryocyte-erythroid progenitor cell
|
Tabula Muris Consortium
|
1.128E-3
|
1.391E-2
|
8.885E-2
|
3.756E-1
|
2
|
192
|
28
|
Facebase ST1 e10.5 Emin MedialNasal 500 3
|
e10.5 Emin MedialNasal top-relative-expression-ranked 500 3
|
FaceBase_ST1
|
1.754E-3
|
2.086E-2
|
1.332E-1
|
5.840E-1
|
2
|
240
|
29
|
Human Cell Atlas Human Cell Atlas HSC HSC Subtype CD34+ HSC-cycle Top 200 Genes
|
Human Cell Atlas Human Cell Atlas HSC HSC Subtype CD34+ HSC-cycle Top 200 Genes
|
|
2.669E-3
|
3.042E-2
|
1.943E-1
|
8.889E-1
|
2
|
297
|
30
|
Human Cell Atlas Human Cell Atlas HSC HSC Subtype CD34+ MultiLin Top 200 Genes
|
Human Cell Atlas Human Cell Atlas HSC HSC Subtype CD34+ MultiLin Top 200 Genes
|
|
2.740E-3
|
3.042E-2
|
1.943E-1
|
9.126E-1
|
2
|
301
|
31
|
GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC eProg Subtype eProg2b Top 200 Genes
|
GSE7638 Midbrain human neurons vs stem cell-derived neurons Platform BrainMap - FluidigmC eProg Subtype eProg2b Top 200 Genes
|
GSE76381_ESMoleculeCountsPMLog2
|
3.401E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
336
|
32
|
10X Human 8K PBMC Immune Subtype Immune-STMN1 TK1 KIAA0101 A Top 200 Genes
|
10X Human 8K PBMC Immune Subtype Immune-STMN1 TK1 KIAA0101 A Top 200 Genes
|
|
3.501E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
341
|
33
|
BrainMap BrainAtlas - Mouse McCarroll Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr Subtype Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr.Dlx1 Top 200 Genes
|
BrainMap BrainAtlas - Mouse McCarroll Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr Subtype Polydendrocyte.polydendrocytes.Bmp4 C1q.Tnr.Dlx1 Top 200 Genes
|
BrainMap
|
3.623E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
347
|
34
|
GSM538358 500
|
B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3
|
Immgen.org, GSE15907
|
4.785E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
400
|
35
|
GSM791108 500
|
Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
4.808E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
401
|
36
|
GSM791114 500
|
Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
4.808E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
401
|
37
|
GSM854317 500
|
Myeloid Cells, MF.BM, B220neg CD3neg Ly-6C/Glo CD115int F4/80+, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
4.808E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
401
|
38
|
GSM791105 500
|
Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
4.832E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
402
|
39
|
GSM605898 500
|
alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3
|
Immgen.org, GSE15907
|
4.832E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
402
|
40
|
GSM791129 500
|
B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2
|
Immgen.org, GSE15907
|
4.879E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
404
|
41
|
GSM791139 500
|
alpha beta T cells, preT.DN2A.Th, Lin-/lo CD25hi CD44+ cKithi, Thymus, avg-2
|
Immgen.org, GSE15907
|
4.997E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
409
|
42
|
GSM399452 500
|
B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3
|
Immgen.org, GSE15907
|
4.997E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
409
|
43
|
GSM538387 500
|
alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3
|
Immgen.org, GSE15907
|
5.021E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
410
|
44
|
GSM476660 500
|
gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3
|
Immgen.org, GSE15907
|
5.117E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
414
|
45
|
GSM854335 500
|
alpha beta T cells, preT.ETP.Th, Lin-/lo CD25- CD44+ cKit+, Thymus, avg-3
|
Immgen.org, GSE15907
|
5.142E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
415
|
46
|
GSM399403 500
|
alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3
|
Immgen.org, GSE15907
|
5.190E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
417
|
47
|
GSM538350 500
|
B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1
|
Immgen.org, GSE15907
|
5.214E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
418
|
48
|
GSM538348 500
|
B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2
|
Immgen.org, GSE15907
|
5.239E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
419
|
49
|
GSM791141 500
|
alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2
|
Immgen.org, GSE15907
|
5.263E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
420
|
50
|
GSM538355 500
|
B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2
|
Immgen.org, GSE15907
|
5.312E-3
|
3.291E-2
|
2.102E-1
|
1.000E0
|
2
|
422
|
Show 45 more annotations
|
15: Computational [Display Chart]
6 input genes in category / 95 annotations before applied cutoff / 10037 genes in category
|
16: MicroRNA [Display Chart]
6 input genes in category / 269 annotations before applied cutoff / 72241 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
hsa-miR-6780b-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
2.295E-5
|
3.662E-3
|
2.261E-2
|
6.173E-3
|
2
|
90
|
2
|
hsa-miR-6765-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
2.723E-5
|
3.662E-3
|
2.261E-2
|
7.324E-3
|
2
|
98
|
3
|
hsa-miR-1304-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.174E-5
|
4.639E-3
|
2.864E-2
|
1.392E-2
|
2
|
135
|
4
|
hsa-miR-10a*:mirSVR highEffct
|
hsa-miR-10a*:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
3.120E-4
|
1.725E-2
|
1.065E-1
|
8.394E-2
|
2
|
332
|
5
|
hsa-miR-155-5p:TargetScan
|
hsa-miR-155-5p
|
TargetScan
|
4.233E-4
|
1.725E-2
|
1.065E-1
|
1.139E-1
|
2
|
387
|
6
|
hsa-miR-4793-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.934E-4
|
1.725E-2
|
1.065E-1
|
1.327E-1
|
2
|
418
|
7
|
hsa-miR-4252:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.839E-4
|
1.725E-2
|
1.065E-1
|
1.571E-1
|
2
|
455
|
8
|
hsa-miR-26a-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
5.890E-4
|
1.725E-2
|
1.065E-1
|
1.584E-1
|
2
|
457
|
9
|
hsa-miR-7703:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.333E-4
|
1.725E-2
|
1.065E-1
|
1.704E-1
|
2
|
474
|
10
|
hsa-miR-508-5p:Functional MTI
|
Functional MTI
|
miRTarbase
|
6.413E-4
|
1.725E-2
|
1.065E-1
|
1.725E-1
|
2
|
477
|
11
|
hsa-miR-933:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
1.743E-3
|
2.837E-2
|
1.751E-1
|
4.689E-1
|
1
|
21
|
12
|
hsa-miR-5687:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
2.489E-3
|
2.837E-2
|
1.751E-1
|
6.696E-1
|
1
|
30
|
13
|
hsa-miR-374c-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
2.986E-3
|
2.837E-2
|
1.751E-1
|
8.033E-1
|
1
|
36
|
14
|
hsa-miR-6821-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.152E-3
|
2.837E-2
|
1.751E-1
|
8.479E-1
|
1
|
38
|
15
|
hsa-miR-4288:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.152E-3
|
2.837E-2
|
1.751E-1
|
8.479E-1
|
1
|
38
|
16
|
hsa-miR-154-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.235E-3
|
2.837E-2
|
1.751E-1
|
8.702E-1
|
1
|
39
|
17
|
hsa-miR-3945:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.401E-3
|
2.837E-2
|
1.751E-1
|
9.148E-1
|
1
|
41
|
18
|
hsa-miR-1251-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.401E-3
|
2.837E-2
|
1.751E-1
|
9.148E-1
|
1
|
41
|
19
|
hsa-miR-632:Functional MTI
|
Functional MTI
|
miRTarbase
|
3.401E-3
|
2.837E-2
|
1.751E-1
|
9.148E-1
|
1
|
41
|
20
|
hsa-miR-1231:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.732E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
45
|
21
|
hsa-miR-517-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.897E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
47
|
22
|
hsa-miR-4728-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
3.897E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
47
|
23
|
hsa-miR-6793-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.063E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
49
|
24
|
hsa-miR-4799-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.146E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
50
|
25
|
hsa-miR-5580-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.228E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
51
|
26
|
hsa-miR-4720-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.228E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
51
|
27
|
hsa-miR-5588-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.228E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
51
|
28
|
hsa-miR-5681b:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.394E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
53
|
29
|
hsa-miR-3667-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.394E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
53
|
30
|
hsa-miR-487a-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.477E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
54
|
31
|
hsa-miR-1-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.477E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
54
|
32
|
hsa-miR-6759-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.642E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
56
|
33
|
hsa-miR-581:Functional MTI
|
Functional MTI
|
miRTarbase
|
4.725E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
57
|
34
|
hsa-miR-4642:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
4.973E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
60
|
35
|
hsa-miR-6741-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.056E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
61
|
36
|
hsa-miR-331-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.221E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
63
|
37
|
hsa-miR-6866-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.221E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
63
|
38
|
hsa-miR-4678:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.552E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
67
|
39
|
hsa-miR-6862-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.635E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
68
|
40
|
hsa-miR-4253:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.717E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
69
|
41
|
hsa-miR-219a-1-3p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.717E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
69
|
42
|
hsa-miR-5002-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
5.965E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
72
|
43
|
hsa-miR-4725-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.048E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
73
|
44
|
hsa-miR-4461:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.131E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
74
|
45
|
hsa-miR-1279:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.296E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
76
|
46
|
hsa-miR-888-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.378E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
77
|
47
|
hsa-miR-369-5p:mirSVR highEffct
|
hsa-miR-369-5p:mirSVR nonconserved highEffect-0.5
|
MicroRNA.org
|
6.709E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
81
|
48
|
hsa-miR-6854-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.874E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
83
|
49
|
hsa-miR-222-5p:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.874E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
83
|
50
|
hsa-miR-3166:Functional MTI (Weak)
|
Functional MTI (Weak)
|
miRTarbase
|
6.957E-3
|
2.837E-2
|
1.751E-1
|
1.000E0
|
1
|
84
|
Show 45 more annotations
|
17: Drug [Display Chart]
6 input genes in category / 1153 annotations before applied cutoff / 22841 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
CID000105028
|
dg-8-AAF
|
Stitch
|
1.660E-9
|
1.276E-6
|
9.735E-6
|
1.915E-6
|
3
|
11
|
2
|
CID000127308
|
BuAdATP
|
Stitch
|
2.214E-9
|
1.276E-6
|
9.735E-6
|
2.552E-6
|
3
|
12
|
3
|
CID000123713
|
BuPdGTP
|
Stitch
|
6.008E-8
|
2.309E-5
|
1.761E-4
|
6.928E-5
|
3
|
34
|
4
|
CID002824289
|
ML60218
|
Stitch
|
1.725E-7
|
3.315E-5
|
2.528E-4
|
1.989E-4
|
2
|
3
|
5
|
CID003541570
|
6-(p-tolylhydrazino)-2-thiouracil
|
Stitch
|
1.725E-7
|
3.315E-5
|
2.528E-4
|
1.989E-4
|
2
|
3
|
6
|
CID000157374
|
AC1L4HWF
|
Stitch
|
1.725E-7
|
3.315E-5
|
2.528E-4
|
1.989E-4
|
2
|
3
|
7
|
CID000131614
|
DCBG
|
Stitch
|
3.450E-7
|
5.682E-5
|
4.334E-4
|
3.977E-4
|
2
|
4
|
8
|
CID000000625
|
AC1Q6S3R
|
Stitch
|
5.718E-7
|
7.365E-5
|
5.617E-4
|
6.593E-4
|
3
|
71
|
9
|
CID000375119
|
NSC654259
|
Stitch
|
5.749E-7
|
7.365E-5
|
5.617E-4
|
6.628E-4
|
2
|
5
|
10
|
CID000368696
|
NSC639828
|
Stitch
|
8.622E-7
|
9.727E-5
|
7.420E-4
|
9.941E-4
|
2
|
6
|
11
|
CID000004156
|
methyl methanesulfonate
|
Stitch
|
9.280E-7
|
9.727E-5
|
7.420E-4
|
1.070E-3
|
4
|
364
|
12
|
CID000065051
|
ddTTP
|
Stitch
|
1.022E-6
|
9.823E-5
|
7.493E-4
|
1.179E-3
|
3
|
86
|
13
|
CID000000646
|
AC1Q6S3Y
|
Stitch
|
1.173E-6
|
9.940E-5
|
7.582E-4
|
1.353E-3
|
3
|
90
|
14
|
CID000162025
|
H2-HPUra
|
Stitch
|
1.207E-6
|
9.940E-5
|
7.582E-4
|
1.392E-3
|
2
|
7
|
15
|
CID000656414
|
2-hydroxydeoxyadenosine 5'-triphosphate
|
Stitch
|
2.069E-6
|
1.491E-4
|
1.137E-3
|
2.385E-3
|
2
|
9
|
16
|
CID000066950
|
isocytosine
|
Stitch
|
2.069E-6
|
1.491E-4
|
1.137E-3
|
2.385E-3
|
2
|
9
|
17
|
ctd:D006147
|
Guanine
|
CTD
|
2.585E-6
|
1.656E-4
|
1.263E-3
|
2.981E-3
|
2
|
10
|
18
|
CID003062886
|
2-(p-n-butylanilino)-2'-deoxyadenosine
|
Stitch
|
2.585E-6
|
1.656E-4
|
1.263E-3
|
2.981E-3
|
2
|
10
|
19
|
CID000000621
|
NSC82625
|
Stitch
|
4.259E-6
|
2.584E-4
|
1.971E-3
|
4.910E-3
|
3
|
138
|
20
|
CID000001151
|
AC1Q6S3S
|
Stitch
|
4.641E-6
|
2.676E-4
|
2.041E-3
|
5.351E-3
|
3
|
142
|
21
|
CID000019518
|
denatonium
|
Stitch
|
5.226E-6
|
2.739E-4
|
2.089E-3
|
6.025E-3
|
2
|
14
|
22
|
CID000452202
|
PMEGpp
|
Stitch
|
5.226E-6
|
2.739E-4
|
2.089E-3
|
6.025E-3
|
2
|
14
|
23
|
CID005311341
|
ATP betaS
|
Stitch
|
6.896E-6
|
3.457E-4
|
2.637E-3
|
7.951E-3
|
3
|
162
|
24
|
ctd:D018053
|
Arsenites
|
CTD
|
7.807E-6
|
3.611E-4
|
2.754E-3
|
9.002E-3
|
2
|
17
|
25
|
CID000449615
|
AC1L9NBB
|
Stitch
|
7.830E-6
|
3.611E-4
|
2.754E-3
|
9.027E-3
|
3
|
169
|
26
|
CID000429118
|
poly(vA
|
Stitch
|
9.814E-6
|
3.902E-4
|
2.976E-3
|
1.132E-2
|
2
|
19
|
27
|
CID000163040
|
aucubigenin
|
Stitch
|
9.814E-6
|
3.902E-4
|
2.976E-3
|
1.132E-2
|
2
|
19
|
28
|
CID000126441
|
5-ClAU
|
Stitch
|
9.814E-6
|
3.902E-4
|
2.976E-3
|
1.132E-2
|
2
|
19
|
29
|
CID000130774
|
dercitin
|
Stitch
|
9.814E-6
|
3.902E-4
|
2.976E-3
|
1.132E-2
|
2
|
19
|
30
|
CID003010960
|
AC1MHT6K
|
Stitch
|
1.090E-5
|
3.918E-4
|
2.989E-3
|
1.257E-2
|
2
|
20
|
31
|
CID000454146
|
OXT-ATP
|
Stitch
|
1.090E-5
|
3.918E-4
|
2.989E-3
|
1.257E-2
|
2
|
20
|
32
|
CID000002028
|
ATP,Gamma S
|
Stitch
|
1.095E-5
|
3.918E-4
|
2.989E-3
|
1.263E-2
|
3
|
189
|
33
|
CID000000640
|
NSC23615
|
Stitch
|
1.166E-5
|
3.918E-4
|
2.989E-3
|
1.344E-2
|
3
|
193
|
34
|
CID000323259
|
parazoanthoxanthin A
|
Stitch
|
1.205E-5
|
3.918E-4
|
2.989E-3
|
1.389E-2
|
2
|
21
|
35
|
CID000122664
|
AC1L3V16
|
Stitch
|
1.205E-5
|
3.918E-4
|
2.989E-3
|
1.389E-2
|
2
|
21
|
36
|
CID000072244
|
U-78036
|
Stitch
|
1.325E-5
|
3.918E-4
|
2.989E-3
|
1.528E-2
|
2
|
22
|
37
|
CID006438779
|
petasiphenol
|
Stitch
|
1.325E-5
|
3.918E-4
|
2.989E-3
|
1.528E-2
|
2
|
22
|
38
|
CID000480107
|
AC1LA211
|
Stitch
|
1.325E-5
|
3.918E-4
|
2.989E-3
|
1.528E-2
|
2
|
22
|
39
|
CID006438404
|
BVdUTP
|
Stitch
|
1.325E-5
|
3.918E-4
|
2.989E-3
|
1.528E-2
|
2
|
22
|
40
|
CID011840913
|
DB07328
|
Stitch
|
1.459E-5
|
4.205E-4
|
3.208E-3
|
1.682E-2
|
3
|
208
|
41
|
CID006857433
|
AC1OAGMB
|
Stitch
|
1.583E-5
|
4.346E-4
|
3.315E-3
|
1.825E-2
|
2
|
24
|
42
|
CID005273539
|
BrVarafUTP
|
Stitch
|
1.583E-5
|
4.346E-4
|
3.315E-3
|
1.825E-2
|
2
|
24
|
43
|
CID005287723
|
AC1NRA6E
|
Stitch
|
1.721E-5
|
4.613E-4
|
3.519E-3
|
1.984E-2
|
2
|
25
|
44
|
CID000000593
|
NSC20261
|
Stitch
|
1.821E-5
|
4.772E-4
|
3.640E-3
|
2.100E-2
|
3
|
224
|
45
|
CID000027281
|
AC1L1CVV
|
Stitch
|
1.864E-5
|
4.775E-4
|
3.642E-3
|
2.149E-2
|
2
|
26
|
46
|
CID000072188
|
araTTP
|
Stitch
|
2.013E-5
|
5.045E-4
|
3.848E-3
|
2.320E-2
|
2
|
27
|
47
|
CID000506602
|
R)-PCV-TP
|
Stitch
|
2.167E-5
|
5.316E-4
|
4.055E-3
|
2.499E-2
|
2
|
28
|
48
|
CID000023985
|
gold nanoparticles
|
Stitch
|
2.323E-5
|
5.367E-4
|
4.094E-3
|
2.679E-2
|
3
|
243
|
49
|
CID003000477
|
UC-3
|
Stitch
|
2.327E-5
|
5.367E-4
|
4.094E-3
|
2.683E-2
|
2
|
29
|
50
|
CID000469173
|
AC1LAIP3
|
Stitch
|
2.327E-5
|
5.367E-4
|
4.094E-3
|
2.683E-2
|
2
|
29
|
Show 45 more annotations
|
18: Disease [Display Chart]
6 input genes in category / 355 annotations before applied cutoff / 16205 genes in category
|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
C0026636
|
Mouth Diseases
|
DisGeNET Curated
|
1.038E-5
|
3.684E-3
|
2.376E-2
|
3.684E-3
|
2
|
14
|
2
|
C0151779
|
Cutaneous Melanoma
|
DisGeNET Curated
|
7.011E-5
|
1.208E-2
|
7.795E-2
|
2.489E-2
|
3
|
250
|
3
|
C0001618
|
Tumors of Adrenal Cortex
|
DisGeNET Curated
|
1.073E-4
|
1.208E-2
|
7.795E-2
|
3.810E-2
|
2
|
44
|
4
|
C0278685
|
Ovarian epithelial cancer stage I
|
DisGeNET BeFree
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
5
|
C0153560
|
Kaposi's sarcoma of skin
|
DisGeNET BeFree
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
6
|
C4016019
|
DNA Ligase I Deficiency
|
DisGeNET BeFree
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
7
|
C3161259
|
Pilar and trichilemmal cysts
|
DisGeNET BeFree
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
8
|
C3273034
|
Moderately Differentiated Hepatocellular Carcinoma
|
DisGeNET BeFree
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
9
|
C4014676
|
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2
|
DisGeNET Curated
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
10
|
cv:CN197312
|
Ataxia-telangiectasia-like disorder 2
|
Clinical Variations
|
3.703E-4
|
1.208E-2
|
7.795E-2
|
1.314E-1
|
1
|
1
|
11
|
C3887499
|
Renal cyst
|
DisGeNET Curated
|
3.745E-4
|
1.208E-2
|
7.795E-2
|
1.329E-1
|
2
|
82
|
12
|
C0341268
|
Disorder of small intestine
|
DisGeNET BeFree
|
7.404E-4
|
1.877E-2
|
1.211E-1
|
2.628E-1
|
1
|
2
|
13
|
C3898352
|
Mild Bronchopulmonary Dysplasia
|
DisGeNET BeFree
|
7.404E-4
|
1.877E-2
|
1.211E-1
|
2.628E-1
|
1
|
2
|
14
|
C0280201
|
stage, Kaposi's sarcoma
|
DisGeNET BeFree
|
7.404E-4
|
1.877E-2
|
1.211E-1
|
2.628E-1
|
1
|
2
|
15
|
C1839736
|
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME
|
DisGeNET Curated
|
1.110E-3
|
2.319E-2
|
1.496E-1
|
3.942E-1
|
1
|
3
|
16
|
C1846009
|
Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies
|
DisGeNET Curated
|
1.110E-3
|
2.319E-2
|
1.496E-1
|
3.942E-1
|
1
|
3
|
17
|
C1370932
|
carcinoma of the renal pelvis and ureter
|
DisGeNET BeFree
|
1.110E-3
|
2.319E-2
|
1.496E-1
|
3.942E-1
|
1
|
3
|
18
|
C0010709
|
Cyst
|
DisGeNET Curated
|
1.433E-3
|
2.502E-2
|
1.614E-1
|
5.089E-1
|
2
|
161
|
19
|
C1412014
|
Infiltrating duct carcinoma
|
DisGeNET BeFree
|
1.480E-3
|
2.502E-2
|
1.614E-1
|
5.255E-1
|
1
|
4
|
20
|
C0334448
|
Cellular Blue Nevus
|
DisGeNET BeFree
|
1.480E-3
|
2.502E-2
|
1.614E-1
|
5.255E-1
|
1
|
4
|
21
|
C1336554
|
T-Cell and NK-Cell Neoplasm
|
DisGeNET BeFree
|
1.480E-3
|
2.502E-2
|
1.614E-1
|
5.255E-1
|
1
|
4
|
22
|
C1333878
|
B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma
|
DisGeNET BeFree
|
1.850E-3
|
2.985E-2
|
1.926E-1
|
6.568E-1
|
1
|
5
|
23
|
C0520573
|
Buffalo hump
|
DisGeNET BeFree
|
2.220E-3
|
3.156E-2
|
2.036E-1
|
7.880E-1
|
1
|
6
|
24
|
C1392224
|
Centrocytic lymphoma
|
DisGeNET BeFree
|
2.220E-3
|
3.156E-2
|
2.036E-1
|
7.880E-1
|
1
|
6
|
25
|
C0022660
|
Kidney Failure, Acute
|
DisGeNET Curated
|
2.222E-3
|
3.156E-2
|
2.036E-1
|
7.889E-1
|
2
|
201
|
26
|
C0259783
|
mixed gliomas
|
DisGeNET BeFree
|
2.589E-3
|
3.193E-2
|
2.060E-1
|
9.192E-1
|
1
|
7
|
27
|
C1841984
|
GLOMUVENOUS MALFORMATIONS
|
DisGeNET Curated
|
2.589E-3
|
3.193E-2
|
2.060E-1
|
9.192E-1
|
1
|
7
|
28
|
C0206622
|
Adenomyoma
|
DisGeNET BeFree
|
2.589E-3
|
3.193E-2
|
2.060E-1
|
9.192E-1
|
1
|
7
|
29
|
C0004238
|
Atrial Fibrillation
|
DisGeNET Curated
|
2.947E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
2
|
232
|
30
|
C0279682
|
Bladder Adenocarcinoma
|
DisGeNET BeFree
|
2.959E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
8
|
31
|
C0262428
|
Collagen-vascular disease
|
DisGeNET BeFree
|
2.959E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
8
|
32
|
C1300347
|
Atypical polypoid adenomyoma
|
DisGeNET BeFree
|
2.959E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
8
|
33
|
C0206736
|
Nevus, Blue
|
DisGeNET BeFree
|
3.328E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
9
|
34
|
C0347129
|
Anal intraepithelial neoplasia
|
DisGeNET BeFree
|
3.328E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
9
|
35
|
C0043037
|
Common wart
|
DisGeNET BeFree
|
3.328E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
9
|
36
|
C0235522
|
Disorder of vein
|
DisGeNET BeFree
|
3.328E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
9
|
37
|
C0334317
|
Cystadenofibroma
|
DisGeNET BeFree
|
3.328E-3
|
3.193E-2
|
2.060E-1
|
1.000E0
|
1
|
9
|
38
|
C0521720
|
Corneal fibrosis
|
DisGeNET BeFree
|
3.697E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
10
|
39
|
C0341038
|
Jaw Keratocyst
|
DisGeNET BeFree
|
3.697E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
10
|
40
|
C0496870
|
Benign neoplasm of liver
|
DisGeNET BeFree
|
3.697E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
10
|
41
|
C0391861
|
Plasma cell inflammation
|
DisGeNET BeFree
|
4.067E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
11
|
42
|
C0035021
|
Relapsing Fever
|
DisGeNET BeFree
|
4.067E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
11
|
43
|
C0206720
|
Squamous Cell Neoplasms
|
DisGeNET Curated
|
4.067E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
11
|
44
|
C3469605
|
PSEUDOHYPOALDOSTERONISM, TYPE IID
|
DisGeNET Curated
|
4.067E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
11
|
45
|
C0004059
|
aspirin intolerance
|
DisGeNET BeFree
|
4.436E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
12
|
46
|
C3665596
|
Warts
|
DisGeNET Curated
|
4.804E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
13
|
47
|
C0751483
|
Familial Retinoblastoma
|
DisGeNET Curated
|
4.804E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
13
|
48
|
C3160738
|
FANCONI ANEMIA, COMPLEMENTATION GROUP D2
|
DisGeNET Curated
|
4.804E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
13
|
49
|
C0742133
|
cervical cancer squamous cell
|
DisGeNET BeFree
|
4.804E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
13
|
50
|
C0278620
|
refractory plasma cell neoplasm
|
DisGeNET BeFree
|
4.804E-3
|
3.280E-2
|
2.116E-1
|
1.000E0
|
1
|
13
|
Show 45 more annotations
|
|